ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106442 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106442; 2) Community: the network communities that were significantly associated with the response to NSC 106442; 3) Molecule: the relationships between components within communities and NSC 106442; 4) MDR: the compounds that were significantly associated with the NSC 106442.

NSC Compound Enrichment Correlation
NSC 696660 (6R,6S)-2,4-Diamino-6-(3,4-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.00957309511256283 -0.03973417
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.00957309511256283 0.10489704
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.00995118568011489 0.50900117
NSC 666388 Null 0.00995118568011489 0.39321391
NSC 699671 Null 0.00995118568011489 0.4556145
NSC 81052 Streptonigrin analog (MeO-N3) 0.00995118568011489 0.6975951
NSC 93131 Helenin 0.00995118568011489 0.40175113
NSC 100880 Camptothecin 0.0105244982742819 -0.025922393
NSC 105014 Cladribine 0.0105244982742819 0.11567924
NSC 132313 Dianhydrogalactitol 0.0105244982742821 0.091507741
Total:108  Current:26    [First] [Prev] [Next] [Last]